论文信息 - Second-line treatment of small-cell lung cancer with the camptothecin-derivative GI147211: a study of the EORTC Early Clinical Studies Group (ECSG). - 字舞流文

Second-line treatment of small-cell lung cancer with the camptothecin-derivative GI147211: a study of the EORTC Early Clinical Studies Group (ECSG).

J. Wanders | C. Sessa | P. Dombernowsky | P. Drings | P. Wissel | R. Morant | A. Hanauske | D. Nielsen | M. Roelvink | J. Wanders | A. Hanauske